Group 1 - The core viewpoint of the articles highlights the collaboration between Nanjing Customs and Suzhou Industrial Park Customs to enhance the efficiency and convenience of customs clearance for the biopharmaceutical industry through the implementation of "intelligent approval" for C2-level low-risk special items [1][2] - A specialized training session was held at the biopharmaceutical customs "care for enterprises" workstation, attracting over 150 companies to participate and engage directly with customs officials to address their needs [1] - The "intelligent approval" system has been successfully implemented in the Nanjing Customs area, with two companies from the Wuxi and Suzhou Industrial Park Customs jurisdictions completing the first pilot work, achieving "second-level" certificate issuance while maintaining strict risk control [1] Group 2 - Suzhou Industrial Park has gathered over 2,000 biopharmaceutical and health enterprises, forming a comprehensive industrial cooperation system with strong competitive capabilities, ranking among the top in the country [2] - The Suzhou Industrial Park Customs has upgraded its "10 measures to support the open innovation of the entire biopharmaceutical industry chain," focusing on optimizing regulatory processes and enhancing customs convenience to boost enterprise competitiveness [2] - Future initiatives will include the continued promotion of joint supervision of special items and "intelligent approval" to ensure the international flow of innovative elements in the biopharmaceutical sector, supporting the development of new productive forces in Suzhou Industrial Park [2]